contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


dagens-aktienyheder-217-danske-bank-mapspeople-og-expres2ion-biotechnologies

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Head of Sales

Jesper Thomsen

Danske Bank was founded in 1871 and is Denmark’s largest bank, with headquarters in Copenhagen and activities in Denmark, Sweden, Norway, Finland, Northern Ireland, and the United Kingdom. Danske Bank is engaged in providing payment services, trading in securities and other instruments, depositing of surplus liquidity and the provision of short- and long-term financing. It operates four commercial business units Personal & Business Customers, Large Corporates & Institutions, Danica Pension, and Northern Ireland.

The Personal & Business Customers segment provides advisory services to personal customers, Private Banking customers and small and medium-sized businesses in Denmark, Sweden, Norway and Finland. Its Large Corporates & Institutions segment is engaged with providing strategic advice, financial solutions and products to large Nordic and institutional customers. Danica Pension provides pension services within Denmark, and in its Northern Ireland segment, Danske Bank serves personal business and corporate customers in Northern Ireland with some activities in targeted sectors across the rest of the United Kingdom.

In 2021 Danske Bank’s market share in Denmark was 25% in lending and 29% in deposits.

Danske Bank

MapsPeople is a Software-as-a-Service (SaaS) company focusing on digital mapping for indoor navigation. The two primary revenue streams are 1) MapsIndoors which is MapsPeople’s own developed mapping solution for indoor navigation 2) Google Maps partnership with Google. MapsIndoors is the key segment with high double-digit growth rates, and the Google Maps segment is expected to be a more steady business going forward.

MapsPeople has a global presence with offices in Denmark, Germany, Singapore and United States, and customers include some of the largest brands in the world. The company has been listed at Nasdaq First North Premier in Denmark since June 2021.

MapsPeople

ExpreS2ion is a Danish-based biotech company listed in Sweden. The company develops a portfolio of vaccines for diseases such as COVID-19, influenza, and breast cancer through the use of its non-viral cell-based expression system, ExpreS2, which is recognized for handling protein challenges. ExpreS2ion has developed Expres2, which is a technology platform for efficient and fast non-clinical development and production of complex proteins for new vaccines and diagnostics.

The company’s current primary product is the corona vaccine candidate, ABNCoV2 in phase 2, co-developed with its partner, AdaptVac of which ExpreS2ion owns 34%. The vaccine candidate has been licensed to Bavarian Nordic has global commercialization rights and responsibility for further clinical development of the vaccine and is expected to initiate phase 3 testing for the product candidate in the first half of 2022.

ExpreS2ion Biotech Holding

Dagens aktienyheder med Danske Bank, MapsPeople og ExpreS2ion Biotechnologies

Dagens aktienyheder 21/7: <a class="ql-mention" spellcheck="false" href="https://www.linkedin.com/company/54143576/admin/page-posts/published/#" data-entity-urn="urn:li:fsd_company:2630" data-guid="2" data-object-urn="urn:li:organization:2630" data-original-text="Danske Bank" data-test-ql-mention="true">Danske Bank</a>, <a class="ql-mention" spellcheck="false" href="https://www.linkedin.com/company/54143576/admin/page-posts/published/#" data-entity-urn="urn:li:fsd_company:102315" data-guid="0" data-object-urn="urn:li:organization:102315" data-original-text="MapsPeople" data-test-ql-mention="true">MapsPeople</a> og <a class="ql-mention" spellcheck="false" href="https://www.linkedin.com/company/54143576/admin/page-posts/published/#" data-entity-urn="urn:li:fsd_company:823192" data-guid="1" data-object-urn="urn:li:organization:823192" data-original-text="ExpreS2ion Biotechnologies" data-test-ql-mention="true">ExpreS2ion Biotechnologies</a>
,Danske Bank var i fredags aktuelle med regnskab for 2. kvartal 2025, og dermed ogs&#xe5; 1. halv&#xe5;r 2025. Regnskabet var uden de helt store overraskelser, og l&#xe5; p&#xe5; de fleste poster inden for markedets forventninger. Derfor var kursreaktionen i fredags ogs&#xe5; begr&#xe6;nset med et plus p&#xe5; 0,3% til kurs DKK 254,90, ligesom Danske Bank allerede er i plus p&#xe5; &#xe5;ret med omkring 25%. Enkelte analytikere har her til morgen justeret deres kursm&#xe5;l p&#xe5; aktien, men forel&#xf8;big ingen anbefalings&#xe6;ndringer i det analytikerkorps der f&#xf8;lger aktien. Husk at vi senere i august, n&#xe5;r de fleste er tilbage fra sommerferie, afholder event med Danske Bank. Det sker onsdag d. 13. august 2025 kl. 14.30. Tilmelding her: <a href="https://www.inderes.dk/videos/danske-bank-praesentation-af-regnskabet-for-2-kvartal-2025" target="_blank" rel="noopener">https://www.inderes.dk/videos/danske-bank-praesentation-af-regnskabet-for-2-kvartal-2025</a>
MapsPeople meldte fredag, at de permanent indstiller deres Aktietilbagek&#xf8;bsprogram, som de i l&#xf8;bet af ugen satte p&#xe5; pause. Et aktietilbagek&#xf8;bsprogram designet til at give private/detail minoritetsaktion&#xe6;rers mulighed for at kunne s&#xe6;lge deres aktier f&#xf8;r afnoteringen. Det er fortsat intentionen, at give disse aktion&#xe6;rer mulighed for at s&#xe6;lge deres aktier efter afnoteringen. MapsPeople-aktien kan fortsat handles p&#xe5; Nasdaq First North Premier til og med den sidste handelsdag den 25. august 2025. l&#xe6;s hele nyheden her: <a href="https://www.inderes.dk/releases/mapspeople-as-permanent-termination-of-share-buy-back-program" target="_blank" rel="noopener">https://www.inderes.dk/releases/mapspeople-as-permanent-termination-of-share-buy-back-program</a>
ExpreS2ion meddelte fredag, at selskabets associerede selskab, AdaptVac (hvor ExpreS2ion ejer 34%), for anden gang indenfor kort tid er en del af et konsortium der modtager et tilskud. Denne gang p&#xe5; EUR 4,6 millioner. Tilskuddet er givet til et japansk-europ&#xe6;iske forskningskonsortium &#x2013; herunder AdaptVac ApS &#x2013; til at udvikle n&#xe6;ste generations malaria-vaccine m&#xe5;lrettet Plasmodium falciparum, den mest d&#xf8;delige art af malariaparasitten globalt. Projektets m&#xe5;l er at fremskynde udviklingen af en ny blodstadie-malaria-vaccine baseret p&#xe5; viruslignende partikler. L&#xe6;s hele nyheden her: <a href="https://www.inderes.dk/releases/expres2ion-biotechnologies-expres2ion-highlights-strategic-relevance-of-ghit-funded-malaria-vaccine-development-through-ownership-in-adaptvac" target="_blank" rel="noopener">https://www.inderes.dk/releases/expres2ion-biotechnologies-expres2ion-highlights-strategic-relevance-of-ghit-funded-malaria-vaccine-development-through-ownership-in-adaptvac</a>
Disclaimer: HC Andersen Capital modtager betaling fra de n&#xe6;vnte selskaber for en digital IR abonnementsaftale. /Jesper Thomsen d. 21/07-2025 kl. 9:06.

Dagens aktienyheder 21/7: Danske Bank, MapsPeople og ExpreS2ion Biotechnologies

Stay up to date